Edition:
United States

NovaBay Pharmaceuticals Inc (NBY)

NBY on American Stock Exchange

2.35USD
28 Jul 2016
Change (% chg)

-- (--)
Prev Close
$2.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,264
52-wk High
$15.45
52-wk Low
$1.62

NBY

Chart for NBY

About

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a... (more)

Overall

Beta: 0.24
Market Cap(Mil.): $21.47
Shares Outstanding(Mil.): 9.15
Dividend: --
Yield (%): --

Financials

  NBY Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -6.10 -- --
ROI: -724.25 -9.57 14.44
ROE: -- -9.91 15.49

BRIEF-Novabay Pharmaceuticals appoints Mark Sieczkarek president and CEO

* On track to achieve target of positive cash flow from operations by end of 2016 & accelerated revenue growth beyond

Jun 13 2016

BRIEF-Novabay Pharmaceuticals files for offering of 581,423 shares of common stock issuable upon exercise of outstanding warrants

* Files for offering of 581,423 shares of co's common stock issuable upon exercise of outstanding warrants Source text (http://1.usa.gov/1UpZZOQ) Further company coverage:

Jun 09 2016

BRIEF-Novabay Pharmaceuticals reports Q1 loss per share $1.24

* Says affirms outlook to reach positive cash flow from operations by end of 2016

May 12 2016

BRIEF-Novabay Pharmaceuticals appoints Todd Zavodnick to its board

* Novabay Pharmaceuticals appoints Todd Zavodnick to its board of directors Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 09 2016

Competitors

  Price Chg
PuriCore plc (PURI.L) 20.25p 0.00
C R Bard Inc (BCR.N) $224.13 -0.12
Smith & Nephew plc (SN.L) 1,243.00p +16.00
Abbott Laboratories (ABT.N) $44.58 +0.13
GlaxoSmithKline plc (GSK.L) 1,691.00p -8.50
3M Co (MMM.N) $178.25 +0.27
Sanofi SA (SASY.PA) €75.32 -0.97
Pfizer Inc. (PFE.N) $36.69 +0.02
Novartis AG (NOVN.S) CHF80.15 -0.15
Johnson & Johnson (JNJ.N) $124.75 +0.29

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.